News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Antero Resources expects materially higher free cash flow in H2 2026.
  • Shares trade around $34.92, implying a steep discount to historical cyclic peaks.
  • Debt/equity stands near 0.31, reducing leverage risk.
  • EV/EBITDA sits near 6, pointing to a cheap valuation.
  • Report outlines entry, stop and target for a 180 trading-day horizon.

Latest Articles

Shaboozey’s “Outlaw” Is Wanted in Every Record Store in America

Shaboozey’s “Outlaw” Is Wanted in Every Record Store in America

Alliance Entertainment Holding Corporation, via its AMPED Distribution division, is orchestrating a comprehensive nationwide retail marketing campaign for Shaboozey’s new album 'The Outlaw Cherie Lee & Other Western Tales.' The campaign integrates independent record stores, major retailers, and e-commerce platforms, featuring listening parties, exc…

Cerenome Launches as an Integrated CNS Oncology Company

Cerenome Launches as an Integrated CNS Oncology Company

Plus Therapeutics, Inc. is rebranding as Cerenome, Inc., with a new Nasdaq ticker CNSY, reflecting its transformation into an integrated central nervous system (CNS) oncology company. Cerenome aims to combine precision diagnostics (CNSide®), targeted radiotherapeutics (REYOBIQ™), and proprietary data analytics powered by artificial intelligence to …

Vistagen Appoints Douglas J. Williamson to its Board of Directors

Vistagen Appoints Douglas J. Williamson to its Board of Directors

Vistagen Therapeutics, a late clinical-stage biopharmaceutical company specializing in intranasal neurocircuitry-focused treatments, announced the appointment of Douglas J. Williamson, MD, to its Board of Directors. Dr. Williamson brings extensive experience in neuroscience drug development and regulatory approvals, expected to strengthen Vistagen'…

Nasdaq Resumes Trading in Inno Holdings Inc.

Nasdaq Resumes Trading in Inno Holdings Inc.

The Nasdaq Stock Market has resumed trading of Inno Holdings Inc. (INHD) at noon on July 31, 2026, following a trading halt that began on June 8, 2026. The reason for the halt was not disclosed in the announcement. Investors can now trade the company’s shares again on Nasdaq.

Cycurion Announces a Warrant Inducement Transaction for $4.5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Cycurion Announces a Warrant Inducement Transaction for $4.5 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Cycurion, a Nasdaq-listed cybersecurity and AI solutions provider, has entered into a warrant inducement transaction with an institutional investor, raising approximately $4.5 million in gross proceeds through the immediate exercise of warrants. In return, the investor receives new warrants to purchase additional shares at a higher exercise price, …

Acciona Shares Drop After H1 Results Reveal Sharply Lower Profitability

Acciona Shares Drop After H1 Results Reveal Sharply Lower Profitability

Acciona's shares fell about 3% after the company reported an 84.3% year-on-year decline in attributable net profit for the first half of 2026, driven by the lack of asset rotation gains that lifted H1 2025 and a swing to a loss at its renewable subsidiary. Management points to July asset disposals and a stronger second half, but investors and analy…

Colgate-Palmolive Holds Annual Sales Outlook as North American Demand Slips

Colgate-Palmolive Holds Annual Sales Outlook as North American Demand Slips

Colgate-Palmolive reaffirmed its full-year net sales guidance after reporting a quarterly sales increase, even as organic sales in North America declined. The company cited volume weakness, market share pressure and inventory reductions at major retailers, while warning that new U.S. tariffs will more than offset recent tariff refunds. Adjusted pro…

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs, announced a technological milestone for their quantum sampling workflow platform, demonstrating a complete end-to-end hybrid quantum-classical analytical process for clinical trial data analytics. This advancement supports processing high-dimensional biomedical datasets with enha…

Barclays Says L'Oreal Stands to Gain as Beauty Market Becomes More Selective

Barclays Says L'Oreal Stands to Gain as Beauty Market Becomes More Selective

Barclays points to L'Oreal as a primary beneficiary of current trends in the European beauty market after Puig reported resilient, selective growth in the first half. While fragrance, makeup and dermocosmetics are expanding, premium skincare has softened as consumers shift toward efficacy and value. Puig's H1 metrics—including 4.4% like-for-like gr…

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

IRADIMED CORPORATION reported Q2 2026 revenue of $20.5 million, a slight increase from Q2 2025, and earnings per share of $0.41 GAAP and $0.46 non-GAAP. The company launched its new 3870 MR IV pump with positive initial market acceptance and expects revenue and earnings growth in the back half of 2026, reaffirming full-year guidance. A quarterly ca…

Moody’s Downgrades Three Carnival Notes After Collateral Was Released

Moody’s Downgrades Three Carnival Notes After Collateral Was Released

Moody's Investors Service lowered the ratings on three Carnival Corporation Ltd. and Carnival UK Ltd. senior note issues to Ba1 from Baa2 after the notes lost secured status when collateral was released. The downgrade affects roughly $3.1 billion of notes, while Moody's kept Carnival's Ba1 corporate family rating and Ba1 senior unsecured rating int…

Buy Fulcrum Now: Cheap Optionality After a Strategic Reset

Buy Fulcrum Now: Cheap Optionality After a Strategic Reset

Fulcrum (FULC) is a speculative buy after the June discontinuation of pociredir and a subsequent strategic review. Market cap trades below the company's stated cash reserves, the pipeline retains clinical promise and the company has time to execute alternatives. This trade idea outlines entry, stop and targets for a mid-term swing position while fl…

Bank of England Seen Slowing Down Bond Sales Pace

Bank of England Seen Slowing Down Bond Sales Pace

A recent survey of market participants indicates the Bank of England is likely to reduce the annual pace at which it is shrinking its government bond holdings to £50 billion in the 12 months ending September 2027, compared with a £70 billion pace in the current 12-month period. The survey, released Friday, mirrors the central bank's previous Market…